Virtual Medicinal Product (VMP)
-
Interferon alfa-2b 18million units/3ml solution for injection vials
Name Details
Current Name
Interferon alfa-2b 18million units/3ml solution for injection vials
|
Start Date
17-01-2007
|
End Date
|
Previous Name
Interferon alfa-2b (rbe) 18million units/3ml solution for injection vials
|
Start Date
03-06-2004
|
End Date
16-01-2007
|
|
Abbreviated Name
Interferon alfa-2b 18million units/3ml inj vials
|
Start Date
01-05-2009
|
|
Interferon alfa-2b 18million units/3ml soln for inj vials |
Previous Start Date
17-01-2007
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 3
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L03AB05
BNF |
Current BNF
08020400
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08020400
|
Start Date
14-02-2005
|
End Date
17-11-2008
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
4452911000001108 |
23-05-2003 |
|
VMP Ingredients
Name
Interferon alfa-2b
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
6
Strength and UOM (Dmr)
1
Virtual Medicinal Product Pack (VMPP) Information